Scholarlink

Purpose <p>Long axial field-of-view (LAFOV) PET/CT systems provide up to 40-fold higher sensitivity than standard digital systems. This study evaluated the impact of reducing acquisition times in [18&#xa0;F]DCFPyL (PSMA) total-body PET/CT to support future research on the development of low-dose protocols.</p> Methods <p>Eighty-five patients with prostate cancer underwent total-body PET/CT on a 194&#xa0;cm-LAFOV system. Standard 8-minute list-mode acquisitions were retrospectively reconstructed into 6-, 4-, and 2-minute datasets. In a subgroup of thirty-three consecutive patients, two experts independently assessed image quality (5-point Likert scale) and E-PSMA criteria. Quantitative analysis (SUVmax, SUVmean) was performed for primary, nodal, and bone lesions.</p> Results <p>In the whole dataset (<i>n</i> = 85) the lesion detection rate (90.5%) and classification consistency between readers and across acquisition times exceeded 95% and remained stable between the 8-minute and 2-minute reconstructions. In a sub-group of thirty-three, no significant differences were found in quantitative parameters across all acquisition times (<i>p</i> &gt; 0.05). While image quality scores improved slightly with longer durations (ranging from 4.50 at 2&#xa0;min to 4.82 at 8&#xa0;min), lesion visibility remained high even at 2&#xa0;min. Changes in physiological background uptake did not impact lesion quantification.</p> Conclusion <p>The preliminary results of the study suggest that LAFOV-PSMA-PET/CT preserves quantitative accuracy and lesion detectability even with acquisition times reduced to 2–4&#xa0;min. These findings demonstrate that high-sensitivity systems might significantly shorten protocols without compromising diagnostic integrity, providing a potential rationale for further optimization of imaging protocols and for future prospective studies specifically designed to evaluate whether the administered radiotracer activity can be safely reduced to ultra-low-dose levels while maintaining diagnostic performance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

LAFOV PSMA PET/CT: Preliminary Report on Protocol Optimization and Future Perspectives in Prostate Cancer Imaging

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月28日

查看全文
  • Pierpaolo Alongi,
  • Albert Comelli,
  • Simone Morea,
  • Viviana Benfante,
  • Roberto Cannella,
  • Daniele Di Biagio

摘要

Purpose

Long axial field-of-view (LAFOV) PET/CT systems provide up to 40-fold higher sensitivity than standard digital systems. This study evaluated the impact of reducing acquisition times in [18 F]DCFPyL (PSMA) total-body PET/CT to support future research on the development of low-dose protocols.

Methods

Eighty-five patients with prostate cancer underwent total-body PET/CT on a 194 cm-LAFOV system. Standard 8-minute list-mode acquisitions were retrospectively reconstructed into 6-, 4-, and 2-minute datasets. In a subgroup of thirty-three consecutive patients, two experts independently assessed image quality (5-point Likert scale) and E-PSMA criteria. Quantitative analysis (SUVmax, SUVmean) was performed for primary, nodal, and bone lesions.

Results

In the whole dataset (n = 85) the lesion detection rate (90.5%) and classification consistency between readers and across acquisition times exceeded 95% and remained stable between the 8-minute and 2-minute reconstructions. In a sub-group of thirty-three, no significant differences were found in quantitative parameters across all acquisition times (p > 0.05). While image quality scores improved slightly with longer durations (ranging from 4.50 at 2 min to 4.82 at 8 min), lesion visibility remained high even at 2 min. Changes in physiological background uptake did not impact lesion quantification.

Conclusion

The preliminary results of the study suggest that LAFOV-PSMA-PET/CT preserves quantitative accuracy and lesion detectability even with acquisition times reduced to 2–4 min. These findings demonstrate that high-sensitivity systems might significantly shorten protocols without compromising diagnostic integrity, providing a potential rationale for further optimization of imaging protocols and for future prospective studies specifically designed to evaluate whether the administered radiotracer activity can be safely reduced to ultra-low-dose levels while maintaining diagnostic performance.